Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
暂无分享,去创建一个
D. Lake | C. Hudis | L. Norton | M. Theodoulou | T. Traina | S. Patil | G. D’Andrea | K. Feigin | P. Drullinsky | Carol L Chen | D. Gajria | Joseph Gonzalez